Local irrigation with tissue factor pathway inhibitor inhibits intimal hyperplasia induced by arterial interventions

Archives of Surgery

Volumn 131, Issue 10, 1996, Pages 1086-1090

  Brown, David M ^a   Kania, Norbert M ^a   Choi, Eric T ^a   Lantieri, Laurent A ^a   Pasia, E Neil ^a   Wun, Tze Chein ^a   Khouri, Roger K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN; THROMBOPLASTIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD FLOWMETRY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION; THROMBOSIS PREVENTION; TRANSMISSION ELECTRON MICROSCOPY; WOUND IRRIGATION;

EID: 0029816614     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430220080018     Document Type: Article

References (31)

1. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty, pathophysiology and prevention. N Engl J Med. 1988;318:1734-1737.
2. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: potential biological determinants and role of intimai hyperplasia. Circulation. 1989;79: 1374-1387.
3. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A. 1989;86:8412-8416.
4. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994;24:1591-601.
5. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol. 1987;18:111-122.
6. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa and protein S as potent mitogens of cuitured aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1975;89:2317-2320.
7. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulfatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 1991; 84:232-243.
8. Ragosta M, Gimple LW, Gertz SD, et al. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 1994;89:1262-1271.
9. Broze GJ Jr, Warren LA, Novotny WF, et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into possible mechanism of action. Blood. 1988;71:335-343.
10. Rao LVM, Rapaport SI. Studies on the mechanism of inactivation of the extrinsic pathway of coagulation. Blood. 1987;69:645-651.
11. Rapaport SI. Inhibition of factor Vlla/tissue factor-induced blood coagulation with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood. 1989;73:359-365.
12. Broze GJ Jr, Girard TJ, Hovotny WF. Regulation of coagulation by a multivalent Kunltz-type inhibitor. Biochemistry. 1990;29:7539-7546.
13. Rapaport SI. The initiation of the tissue factor dependent pathway of blood coagulation. Adv Exp Med Biol 1990;281:97-103.
14. Khouri RK, Koudsi B, Kaiding F, et al. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg. 1993;30:398-404.
15. Ornberg RL, Deune EG, Ozbeck MR, Wun T-C, Khouri RK. Localization of TFPI binding sites in an intimectomized microvessel. Thromb Haemost. 1995;73:55-58.
16. Lantieri LA, Ozbek MR, Deune EG, et al. Prevention of microvascular thrombosis by topical application of tissue factor pathway inhibitor. Plast Reconstr Surg. In press.
17. National Institutes of Health. Guide for Care and Use of Laboratory Animals. Bethesda, Md: National Institutes of Health; 1985. NIH publication 86-23, revised.
18. Diaz-Collier JA, Palmier MS, Kretzmer KK, et al. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli. Thromb Haemost. 1994;71:339-346.
19. Stevens SL, Hilgarth K, Ryan US, Trachtenberg JD, Choi ET, Callow AD. The synergistic effect of hypercholesterolemia and mechanical injury on intimai hyperplasia. Ann Vasc Surg. 1992;6:55-61.
20. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988;318:1714-1719.
21. White CW, Knudson M, Schmidt D, et al. Neither ticlopidine nor aspirindipyridamole prevents restenosis post PTCA: results from a randomized placebo controlled multicenter trial. Circulation. 1987;76(suppl IV):213. Abstract.
22. Mufson L, Black A, Roubin G, et al. A randomized trial of aspirin in PTCA: effect of high vs low dose apirin on major complications and restenosis. J Am Coll Cardiol. 1988;11(suppl A):236A. Abstract.
23. Schanzenbacher P, Grimmer M, Maisch B, et al. Effect of high dose and low dose aspirin on restenosis after primary successful angioplasty. Circulation 1988;78(suppl II):99. Abstract.
24. Knudtson MJ, Flintoft VF, Roth DL, et al. Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1991;15:691-697.
25. Meier B. Prevention of restenosis after coronary angioplasty: a pharmacological approach. Eur Heart J. 1989;10(suppl G):64-68.
26. Ellis SG, Roubin GS, Wilentz J, et al. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
27. Hiebert L, Jaques LB. The observation of heparin on endothelium after injection. Thromb Res. 1976;8:195-204.
28. Hiebert L, Jaques LB. Heparin uptake on endothelium. Artery. 1976;2:26-37.
29. Mahadoo J, Hiebert L, Jaques LB. Vascular sequestration of heparin. Thromb Res. 1977;12:79-90.
30. Lesnik P, Vonica A, Guerin M, Moreau, Chapman MJ. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb Vasc Biol. 1993;13:1066-1075.
31. Palmier MO, Hall LJ, Reisch CM, Baldwin MK, Wilson AGE, Wun T-C. Clearance of recombinant tissue factor pathway inhibitor (TFPI) in ribbits. Thromb Haemost. 1992;68:33-36.